ALYSHA HINSON: Open Payments
NPI 1093349078 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 33 payments from 15 companies in 2025. Trend: 2023 $1,381 · 2024 $568 · 2025 $810
Food & beverage: $711Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 11 | $356 |
| Sage Therapeutics, LLC | 4 | $95 |
| Supernus Pharmaceuticals, Inc. | 2 | $54 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Exeltis, USA Inc. | 2 | $36 |
| MILLICENT US INC | 2 | $34 |
| Seqirus USA Inc | 1 | $33 |
| Evofem Biosciences, Inc. | 2 | $33 |
| PFIZER INC. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
Products named: Veozah, ZURZUVAE, Qelbree, MYFEMBREE, SLYND, Flucelvax, Phexxi, PREVNAR 20.
Industry payments across LA — which companies pay providers there.
